EverGlade Insights Blog
The Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND), through its Accelerated Defense Pharmaceuticals (ADP) program, has issued a Request for Information (RFI) on Prophylactic Platform Technologies for Medical Countermeasures. The...
The National Science Foundation (NSF) has announced From Sequence to Function, a new NSF X-Labs topic supporting platform technologies that connect protein sequence and structure to predictable, controllable biological function. Written proposals are due February...
The National Institute of Allergy and Infectious Diseases (NIAID) has released its 2027 Division of Microbiology and Infectious Diseases (DMID) Omnibus Broad Agency Announcement (BAA) to advance medical interventions for infectious diseases. The solicitation covers...
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released the official solicitation for High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE). The program seeks computational capabilities to...
On October 7, Biohub, The National Institutes of Health (NIH), and U.S. Department of Energy (DOE) announced a major expansion of an international effort to generate open, AI-ready data for predictive models of biology. The...
Date: September 24, 2026 Hosted by: EverGlade and QNova LifeSciences Meet the Panelists Laura Powell, PhD, PMP, Director, Technical Team Lead, EverGlade Tyler Kessler, Director, Finance Team Lead, EverGlade Stephen Richardson, Head of Strategic Partnerships,...